GT BIOPHARMA, INC. (GTBP) Net income 2016–2025
GT BIOPHARMA, INC. (GTBP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$28.4MFY2025 · since FY2016: $9.8M → -$28.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.4M | -115.4% |
| FY2024 | -$13.2M | -73.3% |
| FY2023 | -$7.6M | +63.6% |
| FY2022 | -$20.9M | +64.0% |
| FY2021 | -$58.0M | -105.0% |
| FY2020 | -$28.3M | +26.8% |
| FY2019 | -$38.6M | +85.1% |
| FY2018 | -$259.2M | -79.8% |
| FY2017 | -$144.2M | -1576.0% |
| FY2016 | $9.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice